T Cell Dysfunction and Exhaustion in Cancer
Zhang, Zhen, Liu, Shasha, Zhang, Bin, Qiao, Liang, Zhang, Yi, Zhang, Yi·2020·Frontiers in Cell and Developmental Biology
Cited by (386)
Items 201–300 of 386
- Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial RegimensPaolo Falvo, Stefania Orecchioni, Stefania Roma, Alessandro Raveane, Francesco Bertolini · 2020 · Current Medicinal Chemistry
- Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1Sharon Yunger, Benjamin Geiger, Nir Friedman, Michal Judith Besser, Shimrit Adutler‐Lieber · 2023 · Frontiers in Oncology
- ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemiaNathaly Poveda-Garavito, Carlos A. Orozco, X. Torres, Nataly Cruz‐Rodriguez, Rafael Santiago Parra-Medina, Sandra Quijano, Jovanny Zabaleta, Alba Lucía Cómbita · 2024 · Frontiers in Immunology
- A new era in melanoma immunotherapy: focus on DCs metabolic reprogrammingMina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, Safa Tahmasebi, Sepideh Nasirzadeh Dashtgol, Mahmoud Dehghani-Ghorbi, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad · 2025 · Cancer Cell International
- GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental modelJuan Alberto Hernández-Aceves, Jacquelynne Brenda Cervantes‐Torres, Diana Torres‐García, Francisco J Zuñiga-Flores, Osiris J Patiño-Chávez, Jorge Armando Pena Agudelo, José Eduardo Aguayo-Flores, Yonathan Garfias, Laura Montero, Laura Romero-Romero et al. · 2023 · Cancer Immunology Immunotherapy
- IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast CancerNicholas R. Hum, Aimy Sebastian, Kelly A. Martin, Naiomy Deliz Rios‐Arce, Sean F. Gilmore, David M. Gravano, Elizabeth K. Wheeler, Matthew A. Coleman, Gabriela G. Loots · 2022 · Frontiers in Oncology
- mRNA—From COVID-19 Treatment to Cancer ImmunotherapyW. Kŕause · 2023 · Biomedicines
- Caspase activation in tumour‐infiltrating lymphocytes is associated with lymph node metastasis in oral squamous cell carcinomaPriyanka G. Bhosale, Robert A Kennedy, Fiona M. Watt · 2023 · The Journal of Pathology
- The Association Between Albumin Levels and Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisDeniz Can Güven, Taha Koray Şahin, Enes Erul, Alessandro Rizzo, Angela Dalia Ricci, Şuayib Yalçın · 2022 · Research Square
- Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3Chi‐Wei Liu, Lawrence Shih-Hsin Wu, Chou-Jui Lin, Hsing-Chu Wu, Kuei-Chi Liu, Shih‐Wei Lee · 2024 · PLoS ONE
- Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodiesEdo Kapetanovic, Cédric R. Weber, Marine Bruand, Daniel Pöschl, Jakub Kucharczyk, Elisabeth Hirth, Claudius L. Dietsche, Riyaz Ahmed Khan, Bastian Wagner, Olivier Belli et al. · 2024 · Nature Biomedical Engineering
- Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancerYuyu Xu, Huiling Shen, Dong Shang, Cailin Zhu · 2026 · Frontiers in Oncology
- The transcription factor TOX is involved in the regulation of T-cell exhaustion in neuroblastomaMengmiao Pei, Wenjia Chai, Xiaolin Wang, Yanlong Duan, Hui Wang, Yue Xi, Wenjun Mou, Wei Wang, Xi Chen, Hui Zhang et al. · 2022 · Immunology Letters
- Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapyP.K. Suresh, Arindam Banerjee, Preeti Singh · 2023 · OpenNano
- The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapySylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, Venugopal Balakrishnan · 2021 · Human Vaccines & Immunotherapeutics
- Reviving human γδT cells from apoptosis induced by IL-12/18 via p-JNK inhibitionYuan Song, Huey Yee Teo, Yonghao Liu, Xiaomeng Zhang, Jinmiao Chen, Yongliang Zhang, Haiyan Liu · 2022 · Journal of Leukocyte Biology
- Inducing Immunogenic Cancer Cell Death through Oxygen‐Economized Photodynamic Therapy with Nitric Oxide‐Releasing PhotosensitizersFeijie Xu, Meijun Wang, Eunice Dotse, Kwan Ting Chow, Pui‐Chi Lo · 2024 · Angewandte Chemie
- The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinomaMeng Yang, Dan He, Yu Sun, Yunquan Guo, Yu Ma, Lin Feng, Meng Liu · 2024 · Journal of Translational Medicine
- T cell exhaustion in pediatric B-ALL: current knowledge and future perspectivesTanmaya Atre, Gregor S. D. Reid · 2025 · Frontiers in Immunology
- Ordinary differential equation model of cancer-associated fibroblast heterogeneity predicts treatment outcomesJun-Ho Lee, Eunjung Kim · 2025 · npj Systems Biology and Applications
- Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoidsChristina S. Ennis, Michael Seen, Andrew Chen, Heejoo Kang, Adrian Ilinski, Kiana Mahdaviani, Naomi Yu Ko, Stefano Monti, Gerald V. Denis · 2025 · Communications Biology
- Drug-loaded bispecific T cell nanoengager overcomes T cell exhaustion for potent cancer immunotherapyJinjin Wang, Xisha Huang, Qiangqiang Shi, Kelsey L. Swingle, Alex G. Hamilton, Ningqiang Gong, Michael J. Mitchell · 2025 · Proceedings of the National Academy of Sciences
- Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung CancerJanna Berg, Ann Rita Halvorsen, May‐Bente Bengtson, Morten Lindberg, Bente Lise Halvorsen, Pål Aukrust, Åslaug Helland, Thor Ueland · 2022 · Frontiers in Immunology
- Fluorogenic Granzyme A Substrates Enable Real‐Time Imaging of Adaptive Immune Cell ActivityZhiming Cheng, Emily J Thompson, Lorena Mendive‐Tapia, Jamie I. Scott, Sam Benson, Takanori Kitamura, Ana Senan‐Salinas, Youhani Samarakoon, Edward W. Roberts, Maykel A. Arias et al. · 2022 · Angewandte Chemie
- Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanomaKarolina Wojciechowicz, Katarzyna Kuncewicz, Jacek Rutkowski, Jacek Jassem, Sylwia Rodziewicz‐Motowidło, Anna Wardowska, Marta Spodzieja · 2024 · Biomedicine & Pharmacotherapy
- A comprehensive pan-cancer analysis revealing the role of ITPRIPL1 as a prognostic and immunological biomarkerWenyuan Duan, Wenhao Tian, Zhongyi Li, Yunsong Liu, Linping Xu · 2024 · Frontiers in Molecular Biosciences
- Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder CancerDebashree Basak, Soumya Mondal, Swadeep Kumar Srivastava, Deborpita Sarkar, Ishita Sarkar, Sukanya Basu, Arpita Bhoumik, Snehanshu Chowdhury, Dilip Kumar Pal, Shilpak Chatterjee · 2023 · Cells
- C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferationMesfer Mohammad Al Shahrani, Reem M. Gahtani, Mohammed Makkawi · 2024 · Medical Oncology
- Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF /Pten mouse melanoma modelRafael E. Sanchez‐Pupo, Garth A. Finch, Danielle E. Johnston, Heather C. Craig, Rober Abdo, Kevin Barr, Steven M. Kerfoot, Lina Dagnino, Silvia Peñuela · 2024 · Molecular Oncology
- CD4+ Memory Stem T Cell in Peripheral Blood: A Promising Immune Index for Early Screening and Auxiliary Diagnosis of Colorectal CancerYan Lu, Qiaohong Zhang, Longyi Zhang · 2021 · Frontiers in Oncology
- Targeting cancer-associated glycans as a therapeutic strategy in leukemiaAshraf Abdullah Saad · 2022 · All Life
- Emerging frontiers in adoptive cell therapies: innovations, challenges, and future perspectivesAnmol Dogra, Ranjeet Kumar Yadav, Himanshu Singh, Vimal Datt · 2025 · Medical Oncology
- The Unseen Enemies: Harnessing the Role of Neutrophil Extracellular Traps in Breast Cancer Progression, Immune Evasion, and Treatment ResistanceSomayeh Moradpanah, Shabnam Forouzin, Fatemeh Samadi Nasab, Shahrzad Amirlatifi, Parichehr Shirkosh, Seyed Mehdi Marashi, Nastaran Khodakarim · 2025 · Clinical Breast Cancer
- Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 TrialCaron Alyce Jacobson, Jason R. Westin, David Bernard Miklos, Alex Francisco Herrera, Jerome Ritz, Scott J. Rodig, Yohei Arihara, Subing Cao, Jennifer Sun, Daqin Mao et al. · 2025 · Clinical Cancer Research
- Epigenetic editing to advance CAR T cell therapyLaura Horvathova, Marianne G. Rots, Valerie R. Wiersma · 2026 · Clinical Epigenetics
- Roles of hypoxia in tumor progression and novel strategies for cancer treatmentBui Dinh Khan, Tran Ngo The Nhan, Hoang Nguyen Minh Chau, Nguyen Thi Yen Nhi · 2022 · Biomedical Research and Therapy
- Engineering strategies to optimise adoptive cell therapy in ovarian cancerCatarina Guerra, Milena Kalaitsidou, Gray Kueberuwa, Robert E. Hawkins, Richard John Edmondson · 2023 · Cancer Treatment Reviews
- Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung CancerDavide Ramoni, Simona Coco, Giovanni Rossi, Chiara Dellepiane, Elisa Bennicelli, Sara Santamaria, Linda Zinoli, Alberto Stefano Tagliafico, Marco Tagliamento, Giulia Barletta et al. · 2024 · Lung
- Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beadsLi‐Rong Yang, Lin Li, Mingyao Meng, Wen‐Ju Wang, Songlin Yang, Yiyi Zhao, Run‐Qing Wang, Hui Gao, Weiwei Tang, Yang Yang et al. · 2020 · Journal of Cellular and Molecular Medicine
- Particle elasticity influences polymeric artificial antigen presenting cell effectiveness in vivo via CD8+ T cell activation, macrophage uptake, and the protein coronaSavannah E. Est-Witte, Sydney R. Shannon, Dennis H. Gong, Kaitlyn G. Calabresi, Jawaun J. Harris, Kaitlyn Storm, Edwin Yoo, Ariel Isser, Vivek Jani, Natalie K. Livingston et al. · 2024 · Nano Research
- Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical TrialsSTEPHANIE F. WILLIAMS, Amy A. Ayers, Michelle A.T. Hildebrandt, Lorna Haughton. McNeill, Christopher R. Flowers · 2020 · ONCOLOGY
- Biomaterial nanocarrier-driven mechanisms to modulate anti-tumor immunityLuman Liu, Michael J. Wannemuehler, Balaji Narasimhan · 2021 · Current Opinion in Biomedical Engineering
- Non-small cell lung cancer in the era of immunotherapyQuillan Huang, Jan Ole Kemnade, Loraine Cornwell, Farrah Kheradmand, Anita Lyn Sabichi, Devika Govind Das · 2022 · Seminars in Oncology
- Decisional Capacity Determination in Patients With CancerDaniel Curtis McFarland, Liz Blackler, Fay J. Hlubocky, Rebecca M. Saracino, James N. Masciale, Martin Chin, Yesne Alici, Louis P. Voigt · 2020 · ONCOLOGY
- C chemokines are prognostic biomarkers correlated with diverse immune cell infiltrations in clear cell renal cell carcinomaZhiguo Chen, Ruoyu Wu, Junjie Ma, Junhua Zheng · 2022 · Translational Cancer Research
- S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancerManish Charan, Sanjay R. Mishra, Konstantin Shilo, Xiaoli Zhang, Ajeet Kumar Verma, Pratyusha Ghanta, Amy Webb, Ramesh Kumar Ganju · 2025 · Cell Death and Disease
- Differential RNA expression of immune-related genes and tumor cell proximity from intratumoral M1 macrophages in acral lentiginous melanomas treated with PD-1 blockadeSeoree Kim, Joo Ri Kim, Ji Hyun Lee, Suk-Ho Moon, Su In Jo, Dong‐Jun Bae, Minwoo Park, Sunyoung Lee, Jeong-Oh Kim, Cookjin Lee et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Modeling the Development of Cellular Exhaustion and Tumor-Immune StalemateTyler Simmons, Doron Levy · 2023 · Bulletin of Mathematical Biology
- CAR-T-cell therapy in meningioma: current investigations, advancements and insight into future directionsShree Rath, Murtaja Satea Shafeea, Abbas F. Abdul Hussein, Ahmed Shamil Hashim, Sara Hassanaien, Santiago Pastrana-Brandes, Bipin Kumar Chaurasia · 2024 · Annals of Medicine and Surgery
- Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck CancerPing Wang, Yanli Wang, Yuanjun Jiang, Minghong Li, Guang Li, Qiao Qiao · 2021 · Frontiers in Oncology
- Inhibition of interferon regulatory factor 4 orchestrates T cell dysfunction, extending mouse cardiac allograft survivalWenjia Yuan, Hedong Zhang, Longkai Peng, Chao Chen, Feng Chen, Zhouqi Tang, Pengcheng Cui, Yaguang Li, Tengfang Li, Xia Qiu et al. · 2024 · Chinese Medical Journal
- Response to immune checkpoint inhibitor rechallenge after high-grade immune related adverse events in patients with advanced melanomaPayal C. Shah, Salman Rafi Punekar, Anna C. Pavlick · 2021 · Melanoma Research
- Sialic acid-functionalized nanomaterials for targeted cancer therapy, diagnosis, and theranosticsAbulfazl Vatankhah, Sepehr Hoseinzadeh Moghaddam, Fatemeh Oroojalian, Prashant Kesharwani, Amirhossein Sahebkar · 2025 · International Journal of Pharmaceutics
- Personalizing DNA Cancer VaccinesAnnie A. Wu, Kaiqi Peng, Melanie Vukovich, Michelle Zhu, Yuki Lin, Amrita Bagga, T.‐C. Wu, Chien‐Fu Hung · 2025 · Journal of Personalized Medicine
- Correlation of immune cell subsets in the tumor microenvironment and peripheral blood with immunotherapy response in esophageal squamous cell carcinomaWei Chen, Lian Gong, Yahu Li, Mengyao Wu, Min Tao · 2025 · Frontiers in Immunology
- Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to ImmunotherapyBruce Pell, Aigerim Kalizhanova, Aisha Tursynkozha, Denise Dengi, Ardak Kashkynbayev, Yang Kuang · 2025 · Cancers
- CD93-targeted resveratrol-loaded PLGA nanoparticles remodel CD8⁺ T cell metabolism through AIF-mediated oxidative phosphorylation to overcome lung cancer immunotherapy resistanceZhou Jiang, Yuning Li · 2026 · Journal of Nanobiotechnology
- Interplay between CD28 and PD-1 in T cell immunotherapyZuhayr Jafri, Jingwen Zhang, Connor H. O’Meara, Anthony Michael Joshua, Christopher Richard Parish, Levon Michael Khachigian · 2024 · Vascular Pharmacology
- Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer modelJuan Alberto Hernández-Aceves, Jacquelynne Brenda Cervantes‐Torres, Alfredo Cruz‐Gregorio, Ana Karina Aranda‐Rivera, Diego Moctezuma-Rocha, Jorge Armando Pena Agudelo, Osiris J Patiño-Chávez, Marisela Hernández, Sergio Sifontes, Tonathiu Rodríguez et al. · 2025 · Vaccine
- Immunotherapy in the complex treatment of tumor diseasesVictor Ivanovich Seledtsov, Galina Victorovna Seledtsova, Доржиева Аяна Баяровна, Irina P. Ivanova · 2022 · Siberian Journal of Oncology
- Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effectFelipe Ángel Calvo, Adriana Ayestarán, Javier Serrano, Mauricio Cambeiro, Jacobo Palma, Rosa M. Meirino, Miguel Ángel Morcillo, Fernando Lapuente, Luis M. Chiva, Borja Aguilar et al. · 2022 · Frontiers in Oncology
- Immune Modulatory Profile of the Pateamines PatA and Des-Methyl Des-Amino PatASusanne Schiffmann, Marina Henke, Sophie Brünner, Alexandre Bennett, Yassin Yagubi, F. Magari, Michael John Parnham, Arnold Grünweller · 2024 · International Journal of Molecular Sciences
- PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccineKazuki Akutagawa, Shunichiro Miki, Erika Yamada, Noriaki Sakamoto, Tsubasa Miyazaki, Narushi Sugii, Alexander Zaboronok, Masahide Matsuda, Eiichi Ishikawa · 2025 · Journal of Neuro-Oncology
- Cutaneous Squamous Cell Carcinoma in Immunocompromised PatientsSoo Hyun Hwang, Maie A. St. John · 2025 · Cancers
- Tumor Microenvironment-Driven CD8⁺ T Cell Exhaustion: Mechanisms, Therapeutic Implications, and Strategies for ReinvigorationReza Izadfar, Ali Alishvandi · 2025 · The Cancer Review
- Immune checkpoint crosstalk between LAG-3 and CD39/CD73 in glioblastoma: dual-pathway regulation of metabolic exhaustion and therapeutic reversal strategiesDr. Arpita Mukherjee · 2026 · Journal of the Egyptian National Cancer Institute
- PAX5 haploinsufficiency induced CD8+ T cells dysfunction or exhaustion by high expression of immune inhibitory-related moleculesLiang Mi, Duanhao Gong, Lei Wang, Xue Liang, Jiao Meng, Wei Huang, Jianfeng Zhou · 2021 · Cancer Treatment and Research Communications
- Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patientsAna Cristina Olivas‐Bejarano, Laura Arcelia Montiel‐Cervantes, Flor Perez-Retiguin, Sócrates Alberto García-Gutiérrez, Teresita Rocío Cruz-Hernández, Ruth Angelica Lezama-Palacios, Elba Reyes‐Maldonado, Jorge Vela‐Ojeda · 2023 · Annals of Hematology
- Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic MelanomaChristy Los, Sebastian Klobuch, John B.A.G. Haanen · 2024 · The Cancer Journal
- Soluble MIC‐A , IPI , and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphomaJorge Vela‐Ojeda, Ana Cristina Olivas‐Bejarano, Laura Arcelia Montiel‐Cervantes, Érika Rosales-Cruz, Sócrates Alberto García-Gutiérrez, Ruth Angelica Lezama-Palacios, Elba Reyes‐Maldonado · 2024 · European Journal Of Haematology
- Incidence of Post-therapeutic Malignancies in Benign and Malignant Gastric Diseases, Human Leukocyte Antigen-restricted Human Endogenous Retrovirus Gene-derived Peptides, and SurvivalKyoji Ogoshi, Kunihiro Iwata, Chikara Kunisaki, Seiichi Takenoshita, K Isono · 2024 · Annals of Cancer Research and Therapy
- Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysisJinqiao Li, Xiaoxia Li, Yueyue Fu, Hongbin Meng, Dan Xu, Wenyi Hou · 2024 · Human Vaccines & Immunotherapeutics
- Exploring neuroblastoma’s cellular microenvironment: A novel approach using cellular automata to model Celyvir treatmentJosé García Otero, Juan Belmonte-Beitia, Juan Jiménez-Sánchez · 2025 · Computers in Biology and Medicine
- Epigenetic programming of the immune responses in cancerAbbey A. Saadey, Amir Yousif, Hazem E. Ghoneim · 2021 · Elsevier eBooks
- Induced pluripotent stem cells–derived hematopoietic progenitors for cellular immunotherapiesIgor I. Slukvin, Saritha Sandra D'Souza, Akhilesh Kumar · 2021 · Elsevier eBooks
- Pollock: fishing for cell statesErik P. Storrs, Daniel Cui Zhou, Michael C. Wendl, Matthew A. Wyczalkowski, Alla Y. Karpova, Liang-Bo Wang, Yize Li, Austin N. Southard-Smith, Reyka G. Jayasinghe, Lijun Yao et al. · 2022 · Bioinformatics Advances
- The Correlation between Peripheral Blood Index and Immune Cell Expansion in Vietnamese Elderly Lung Cancer PatientsHoang-Phuong Nguyen, Viet Anh Bui, Ai-Xuan Thi Hoang, Phong Van Nguyen, Dac-Tu Nguyen, Hien Thi, Hai-Anh Le, Thanh-Luan Nguyen, Hoang Thi My Nhung, Nguyễn Thanh Liêm et al. · 2023 · International Journal of Molecular Sciences
- Characterization of the adaptive cellular and humoral immune responses to persistent colonization of Brucella abortus strain RB51 in a Jersey cowPaola Mercedes Boggiatto, Haley M. Sterle, Shollie M. Falkenberg, Kaitlyn M. Sarlo Davila, Ellie J. Putz, Steven C. Olsen · 2024 · Frontiers in Veterinary Science
- The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatmentVanessa Cristaldi, Lodovico Terzi di Bergamo, Lucrezia Patruno, Marinos Kallikourdis, Giada Andrea Cassanmagnago, Francesco Corrado, Eleonora Calabretta, Adalgisa Condoluci, Martina Di Trani, Daoud Rahal et al. · 2025 · Frontiers in Oncology
- Prostate Cancer Vaccines: Progress, Challenges, and Future DirectionsStefanus Vicky Bernhard Elisa Runtunuwu, Trina Ekawati Tallei, Grace L. A. Turalaki · 2025 · Heca Journal of Applied Sciences
- Perfluorohexane Emulsions Induce Macrophage-Stimulating Effects through iNOS ExpressionRuoqi Gao, Ethan Wang, Victor Pineiro, Lalit Chudal, Julien Santelli, Connor Endsley, Adam Woodward, Caroline de Gracia Lux, Jacques Lux, Robert F. Mattrey · 2025 · ACS Applied Bio Materials
- Sex differences, family history of cancer, association with peptides matching the human endogenous retrovirus genes, and survivalKyoji Ogoshi, Kunihiro Iwata, Seiichi Takenoshita · 2025 · Annals of Cancer Research and Therapy
- Tumor-Draining Lymph Node-Targeted Electrochemotherapy: A Hypothesis for In Situ Cancer VaccinationReihane Mahdavi, Hossein Ataee, Amirparsa Abdollahian Dehkordi, Mahdi Shabani, Azam Hemati, Mohammad Abdolahad · 2025 · Biomedicines
- Antioxidant N-Acetylcysteine Facilitates Breast Cancer Metas-Tasis via Immunosuppressive Reprogramming of NeutrophilsJin Zhang, Di Wang, Huige Wang, Qiuyu Wu, Menghao Liu, Qing Li, Zheng Gong · 2026 · International Journal of Molecular Sciences
- Pre-treatment endocrine–nutritional signatures predict clinical benefit from PD-1/PD-L1 blockade in hematologic malignanciesNingjing Huang, Yu Guan · 2026 · Frontiers in Nutrition
- Exploring the Potential of Receptor Silencing in the Tumor Microenvironment by RNA InterferenceKARINA MAYUMI TANI BEZERRA DE MELO, Beatriz Mendonça Alves Bandeira, Pedro Vinícius Silva Novis, Micaela Evellin dos Santos Silva, Ingrid Andrêssa de Moura, Antônio Carlos de Freitas, Anna Jéssica Duarte Silva · 2026 · Biomolecules
- Low intensity vibration as a novel strategy to normalize age-related deficits in T cell proliferation, activation, and functionChristopher P. Ashdown, Ankur Sikder, Andreas G. Kaimis, Meilin Ete Chan, Brian S. Sheridan, Clinton T. Rubin · 2026 · Scientific Reports
- Reversing T cell dysfunction in a novel in vitro model of T cell exhaustion reveals differential roles of RASA2Hilal Saraç, Rachael Nicholson, Rebecca N. Graham, Meera Augustus, R. Taghavi, Dympna J. Connolly, Lindsay Lim, Sofia Da Silva Lourenco · 2026 · Frontiers in Immunology
- Radiotherapy as an immunomodulator in cancer: Synergy with immunotherapy and roadmap for optimizationChenyi Zhao · 2026 · Journal of Radiation Research and Applied Sciences
- Remodeling the Tumor Immune Microenvironment by Traditional Chinese Medicine: Mechanisms Focusing on TAM Polarization and CD8 + T Cell ExhaustionYannan Geng, Yuanjun Qu, Ji Li, X Wang, Changying Ji, Guangze Wang · 2026 · Journal of Biochemical and Molecular Toxicology
- Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: molecular docking, dynamics, & STRING protein-protein network analysisMahmoud Elkazzaz, Shahid Ullah, Tianshun Gao, Israa Mohamed Shamkh, Amr Kamel Khalil Ahmed, Ted X. Wu, Maii S. Elsharayidi, Mohammad Shahbaz Khan, Aziz-ur Rehman, Marwa M. Lotfy et al. · 2023 · Informatics in Medicine Unlocked
- Survivin‐Based Recombinant Overlapping Peptides Induce T Lymphocyte Cytotoxicity and Prolong the Survival in In Vivo Melanoma ModelYuan‐Ting Zhang, Yihan Zhou, Min Gong, Qing Zhang, Qiujie Zheng, Yuanying Shen, Wenshu Lu, Shisong Jiang · 2023 · Advanced Therapeutics
- Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principleJonas Steenbrugge, Glenn Pauwelyn, Kristel Demeyere, Nausikaa Devriendt, H. de Rooster, Niek N. Sanders, Jan H. Spaas, Evelyne Meyer · 2023 · Frontiers in Immunology
- The Mechanism of Action of Cancer Therapeutic Vaccines and Their Application ProspectsMingrui Li · 2024 · Transactions on Materials Biotechnology and Life Sciences
- Effects of reprogrammed splenic CD8+ T-cells in vitro and in mice with spontaneous metastatic Lewis lung carcinomaЕ. G. Skurikhin, N. Ermakova, М. А. Zhukova, Edgar Sergeevich Pan, Darius Widera, Lubov Alexandrovna Sandrikina, Lena Kogai, О. V. Pershina, A. Pakhomova, V. Yu. Pan et al. · 2024 · BMC Cancer
- Implication of T Cell Exhaustion in Neuropsychiatric Disorders: Neuroimmunopathology and Treatment StrategiesKiarash Saleki, Nima Rezaei · 2024 · Integrated science
- Molecular Biology of Urothelial CarcinomaPeir‐In Liang, Ti‐Chun Chan, Yow‐Ling Shiue, Chien‐Feng Li · 2021 · Journal of Cancer Research and Practice
- Single-cell Sequencing: The Technological Revolution Behind a New Wave of Multiomic Studies in Basic and Cancer ResearchTristan Free · 2021 · BioTechniques
- Pretreatment Immune Status, Predicts Response to Definite Chemo Radiotherapy in Advanced Stages of Cervical Cancer PatientsSwati Garg, Usha Shekhawat, Rajaat Vohra, Reshu Gupta · 2022 · The Journal of Obstetrics and Gynecology of India
- An update on novel multiple myeloma targetsMassimo Offidani, Laura Corvatta, Sonia Morè, Valentina Maria Manieri, Attilio Olivieri · 2022 · Expert Review of Hematology